维普期刊资源整合服务平台（V6.5）

83篇 您的检索式：作者名="SHAWVERS"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Solvent Swelling Studies of Two Low-rank Coals显示文摘	Larsen J Shawver S	1990	Energy and Fuels1990，4，1：	1
2	Glioblastoma growth inhibited in vitro by a dominantnegative Flk-1 mutant显示文摘	Millauer B Shawver LK Plate KH	1994	Nature1994，367，6463：	1
3	SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors显示文摘	Laird AD Vajkoczy P Shawver LK	2000	Cancer Res2000，60，15：	1
4	SU5416 is a potent and selective inhibitor of the vascularendothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis,tumorvascularization,and growth of multiple tumortypes显示文摘	Fong TA Shawver LK Sun L	1999	Cancer Res1999，59，：	1
5	New paradigms for the treatment of cancer: the role of anti - angiogenesis agents 显示文摘	Cherrington JM Strawn LM Shawver LK	2000	Adv Cancer Res2000，79，：	1
6	Smart drugs: tyrosine kinase inhibitors in cancer therapy 显示文摘	Shawver L K Slamon D Ullrich A	2002	Cancer cell2002，1，2：	1
7	Treatment-Related Pro- tein Biomarker Expression Differs between Primary and Recurrent Ovarian Carcinomas显示文摘	Zajchowski DA Karlan BY Shawver LK	2012	Mol Cancer Ther2012，11，2：	1
8	SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors显示文摘	LAIRD AD Vajkoczy P Shawver LK		0，，：	1
9	SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor ( Flk - 1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types 显示文摘	FONG T A SHAWVER L K SUN L	1999	Cancer Research1999，59，1：	1
10	Tyrosine kinase inhibitors in cancer therapy显示文摘	Shawver LK Slamon D Ullrich A	2002	Cancer Cell J2002，1，：	1
11	Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N- 5-methylisoxazole-4-carboxamide 显示文摘	Shawver LK Schwartz DP Mann E	1997	Clin Cancer Res1997，3，7：	1
12	New paradigms for the treatment of cancer; the role of antiangiogenesisagents显示文摘	Cherrington JM Strawn LM Shawver LK	2000	Advan Cancer Res2000，79，1：	1
13	SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types 显示文摘	Fong TA Shawver LK Sun L	1999	Cancer Res1999，59，1：	1
14	Effect of demineralizationon the macroruolecular structure of coals显示文摘	LARSEN J W PAN C S SHAWVER S	1989	Energy Fuels1989，3，5：	1
15	Glioblastoma growth inhibited in vivo by a dominant-negative klf-1 mutant 显示文摘	Millauer B Shawver LK Plate KH	1994	Nature1994，367，：	1
16	SU6668 is a potent antiangiogenic and antitumor agent that induces regression of astablished tumors 显示文摘	Laird AD Vajkoczy P Shawver LK	2000	Cancer Res2000，60，15：	1
17	Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant 显示文摘	Millauer B Shawver L K Plate K H	1994	Nature1994，367，6463：	1
18	SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors显示文摘	LAIRD AD VAJKOCZY P SHAWVER LK	2000	Cancer Res2000，60，15：	1
19	SU6688 is a potent anti-tumor agent that induces regression of established tumors显示文摘	Laird A Vajkoczy P Shawver L	2000	J Cancer Res2000，60，15：	1
20	Solvent Swelling Studies of Two Low-rank Coals显示文摘	Larsen J Shawver S	1990	Energy and Fuels1990，4，1：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示